Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net product sales
0
0
0
0
19
7
Non-recurring engineering revenues
0
0
0
0
0
1
Total net revenues
61
37
23
19
19
8
Cost of sales
40
27
20
15
15
6
Gross Profit
20
9
3
4
4
2
Research and development
15
13
5
5
5
6
Intellectual property legal fees
0
0
2
6
6
6
Selling, general and administrative
11
10
6
7
7
8
Total operating expenses
26
23
13
18
18
19
Operating loss
-5
-14
-10
-14
-14
-17
Interest expense, net
0
0
-1
-2
-2
-2
Realized loss on sale of marketable securities reclassified from other comprehensive loss
0
0
0
0
0
0
Other expense, net
0
0
0
0
0
-1
Total other expense, net
0
0
-1
-2
-2
-3
Loss before provision for income tax
-6
-14
-11
-15
-15
-21
Provision for income taxes
0
0
0
0
0
0
Net loss
-6
-14
-11
-15
-15
-21
Unrealized loss transferred from other comprehensive loss to earnings
0
0
0
0
0
0
Comprehensive loss
0
-14
0
0
0
0
Remarks
restated on Mar 29, 2013 n/a
calculated values,
restated on Mar 18, 2014 n/a
calculated values,
restated on Mar 27, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
11
8
7
11
11
20
Restricted cash
0
0
1
1
1
0
Investment in marketable securities
0
0
0
0
0
0
Accounts receivable, net of allowances
11
3
5
1
1
1
Inventories
6
7
3
2
2
2
Prepaid expenses and other current assets
1
1
1
1
1
2
Total current assets
29
20
16
16
15
24
Property and equipment, net
3
3
1
0
0
0
Long-term investments in marketable securities
0
0
0
0
0
0
Other assets
0
0
0
0
0
0
Total assets
32
22
18
16
16
25
Liabilities and owners' equity
Accounts payable
6 6155000
3 3367000
4 3795000
4 3957000
4 3957000
3 3299000
Accrued payroll and related liabilities
2 1813000
1 784000
1 635000
1 710000
1 710000
1 1243000
Accrued expenses and other current liabilities
0 460000
0 497000
1 533000
0 420000
0 420000
0 340000
Deferred revenue
0 0
0 0
0 0
0 0
0 0
7 6857000
Accrued engineering charges
0 450000
0 450000
1 500000
1 500000
1 500000
1 500000
Current portion of long-term debt, net of debt discount
2 2144000
3 3493000
0 0
2 2205000
2 1952000
0 13000
Total current liabilities
11 11022000
9 8591000
5 5463000
8 7792000
8 7539000
12 12252000
Long-term debt, net of current portion and debt discount
1 1118000
0 0
5 5099000
4 3632000
4 3551000
14 13699000
Long-term warranty liability
0 94000
0 94000
0 100000
0 99000
0 99000
0 49000
Total liabilities
12 12234000
9 8685000
11 10662000
12 11523000
11 11189000
26 26000000
Commitments and contingencies
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
0 26000
0 30000
0 31000
0 41000
0 41000
0 50000
Additional paid-in capital
93 92709000
100 100403000
104 104469000
118 117546000
118 117546000
132 132011000
Accumulated deficit
-73 -72740000
-87 -86721000
-97 -97487000
-113 -112868000
-113 -112868000
-133 -133395000
Accumulated other comprehensive loss
0 -56000
0 0
0 0
0 0
0 0
0 0
Total stockholders' (deficit) equity
20 19939000
14 13712000
7 7013000
5 4719000
5 4719000
-1 -1334000
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
32 32173000
22 22397000
18 17675000
16 16242000
16 15908000
25 24666000
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (36 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
-6
-14
-11
-15
-15
-21
Depreciation and amortization
2
2
1
1
1
0
Capitalized payment in kind interest
0
0
0
0
0
0
Amortization of debt discount and debt issuance costs
0
0
0
1
1
1
Realized loss on sale of investments in marketable securities
0
0
0
0
0
0
Realized (gain) loss on sale of equipment
0
0
0
0
0
0
Provision for bad debts
0
0
0
0
0
0
Stock-based compensation
2
2
2
2
2
2
Issuance of warrant in lieu of payment
0
0
0
0
0
0
Issuance and repricing of warrants
0
0
0
0
0
1
Restricted cash
0
0
-1
0
0
0
Accounts receivable
-5
8
-1
4
4
0
Inventories
-2
-1
5
1
1
0
Prepaid expenses and other assets
1
0
0
0
0
-1
Other assets
0
0
0
0
0
0
Accounts payable
0
-3
0
0
0
-1
Accrued payroll and related liabilities
0
-1
0
0
0
1
Accrued expenses and other current liabilities
0
0
0
0
0
0
Accrued engineering charges
0
0
0
0
0
0
Deferred revenue
0
0
0
0
0
7
Net cash used in operating activities
-7
-7
-4
-6
-6
-9
Acquisition of property and equipment
-1
-2
0
0
0
0
Proceeds from sale of equipment
0
0
0
0
0
0
Proceeds from maturities and sales of investments in marketable securities
1
0
0
0
0
0
Net cash used in investing activities
1
-2
0
0
0
0
Borrowings on lines of credit
1
3
0
0
0
0
Payments on lines of credit
-1
-3
0
0
0
0
Proceeds from long- term loans, net of issuance costs
3
1
2
0
0
19
Payments on debt
-2
-1
-1
0
0
-11
Proceeds from issuance of common stock, net
2
5
1
10
10
11
Proceeds from exercise of equity awards, net of taxes remitted for restricted stock
0
1
0
1
1
0
Net cash provided by financing activities
3
6
3
11
11
18
Net change in cash and cash equivalents
-4
-3
-1
4
4
9
Remarks
restated on Mar 29, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo